Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AXDX NASDAQ:BNGO NASDAQ:DAIO NASDAQ:OLIT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAXDXAccelerate Diagnostics$0.65$0.03▼$2.09$857K0.22557,553 shs53.64 million shsBNGOBionano Genomics$3.45+1.6%$3.54$2.68▼$40.20$11.53M2.2112,038 shs68,159 shsDAIOData I/O$3.24+1.1%$2.86$1.88▼$3.24$29.66M0.9826,316 shs16,069 shsOLITOmniLit Acquisition$1.59+20.5%$2.52$7.55▼$19.50$9.76M0.0550,949 shs361,857 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAXDXAccelerate Diagnostics0.00%0.00%0.00%-92.36%-96.38%BNGOBionano Genomics0.00%+0.88%+7.19%-14.25%-90.40%DAIOData I/O0.00%+2.72%+12.63%+61.31%+16.73%OLITOmniLit Acquisition0.00%+18.66%+23.26%+28.23%-8.62%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAXDXAccelerate Diagnostics1.3678 of 5 stars0.00.00.04.72.21.70.6BNGOBionano Genomics1.7555 of 5 stars3.14.00.00.00.90.00.6DAIOData I/O1.2121 of 5 stars2.05.00.00.00.61.70.0OLITOmniLit AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAXDXAccelerate Diagnostics 4.00Strong BuyN/AN/ABNGOBionano Genomics 2.25Hold$7.00102.66% UpsideDAIOData I/O 4.00Strong Buy$5.2261.36% UpsideOLITOmniLit Acquisition 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest OLIT, DAIO, AXDX, and BNGO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/8/2025DAIOData I/OWestpark CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy$5.22(Data available from 7/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAXDXAccelerate Diagnostics$11.70M0.00N/AN/A($1.37) per share0.00BNGOBionano Genomics$30.78M0.38N/AN/A$18.12 per share0.19DAIOData I/O$21.77M1.37N/AN/A$1.91 per share1.69OLITOmniLit AcquisitionN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAXDXAccelerate Diagnostics-$61.62M-$2.34N/AN/AN/A-471.83%N/A-191.66%N/ABNGOBionano Genomics-$112.02M-$138.92N/A∞N/A-294.05%-125.75%-71.96%8/6/2025 (Estimated)DAIOData I/O-$3.09M-$0.29N/A∞N/A-12.21%-14.56%-10.84%7/24/2025 (Estimated)OLITOmniLit AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/ALatest OLIT, DAIO, AXDX, and BNGO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2025Q2 2025BNGOBionano Genomics-$2.69N/AN/AN/A$6.90 millionN/A5/14/2025Q1 2025BNGOBionano Genomics-$3.49-$1.15+$2.34-$1.15$6.25 million$6.46 million4/24/2025Q1 2025DAIOData I/O-$0.09-$0.04+$0.05-$0.04$5.30 million$6.18 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAXDXAccelerate DiagnosticsN/AN/AN/AN/AN/ABNGOBionano GenomicsN/AN/AN/AN/AN/ADAIOData I/ON/AN/AN/AN/AN/AOLITOmniLit AcquisitionN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAXDXAccelerate DiagnosticsN/A1.501.34BNGOBionano Genomics0.071.701.34DAIOData I/ON/A4.203.04OLITOmniLit AcquisitionN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAXDXAccelerate Diagnostics17.14%BNGOBionano Genomics11.35%DAIOData I/O36.95%OLITOmniLit Acquisition21.61%Insider OwnershipCompanyInsider OwnershipAXDXAccelerate Diagnostics43.60%BNGOBionano Genomics0.90%DAIOData I/O7.30%OLITOmniLit Acquisition78.04%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAXDXAccelerate Diagnostics22025.21 million14.13 millionOptionableBNGOBionano Genomics3003.36 million3.33 millionOptionableDAIOData I/O1009.24 million8.57 millionOptionableOLITOmniLit Acquisition36.14 million1.35 millionNot OptionableOLIT, DAIO, AXDX, and BNGO HeadlinesRecent News About These CompaniesOMB Requirements for AI Acquisition Will Impact Government ContractorsOctober 7, 2024 | jdsupra.comRegal Rexnord (NYSE:RRX) Stock Quotes, Forecast and News SummaryOctober 2, 2024 | benzinga.comSam Altman says it’s relentless and all-consuming to run OpenAI teams after shock CTO departureSeptember 28, 2024 | aol.comADarioHealth (NASDAQ:DRIO) Stock Quotes, Forecast and News SummaryAugust 20, 2024 | benzinga.comDelivering for the Warfighter: The Importance of Executing Space Acquisition ProgramsFebruary 24, 2024 | csis.orgCCorrection: Syntec Optics, Inc., a Leading Advanced Manufacturing Company, Completes Business Combination with OmniLit (Nasdaq: OLIT) and will Commence Trading on Nasdaq Under Ticker Symbol “OPTX”November 7, 2023 | finance.yahoo.comSyntec Optics, Inc., a Leading Advanced Manufacturing Company, Completes Business Combination with OmniLit (Nasdaq:OLIT) and Will Commence Trading on Nasdaq Under Ticker Symbol “OPTX”November 7, 2023 | finance.yahoo.comSyntec Optics, Inc. Listing on Nasdaq via Merger with OmniLit (Nasdaq: OLIT) Announces NASDAQ Opening Bell Ringing to CelebrateNovember 7, 2023 | finance.yahoo.comWhy Is EnGene (ENGN) Stock Up 8% Today?November 2, 2023 | markets.businessinsider.comWhy Is OmniLit Acquisition (OLIT) Stock Up 61% Today?November 2, 2023 | msn.comOmniLit Acquisition Corp. Shareholders Approve Syntec Optics MergerOctober 31, 2023 | finance.yahoo.comOmniLit Acquisition Corp.: Syntec Optics, Pioneering Revolutionary Space Economy, to List on Nasdaq via Merger with OmniLit (Nasdaq: OLIT)October 24, 2023 | finanznachrichten.deSyntec Optics, Pioneering Revolutionary Space Economy, to List on Nasdaq via Merger with OmniLit (Nasdaq: OLIT)October 23, 2023 | finance.yahoo.comSyntec Optics, Merging with OmniLit (Nasdaq: OLIT), to Exhibit at SPIE Optifab 2023October 16, 2023 | finance.yahoo.comOmniLit Acquisition Corp.: Syntec Optics, Merging with OmniLit (Nasdaq: OLIT), Reshores Night Vision OpticsOctober 10, 2023 | finanznachrichten.deSyntec Optics, Merging with OmniLit (Nasdaq: OLIT), Reshores Night Vision OpticsOctober 10, 2023 | finance.yahoo.comOmniLit Acquisition Corp. (Nasdaq: OLIT) Announces Effectiveness of Registration Statement and October 31, 2023 Annual Meeting of Stockholders to Approve Business Combination with Syntec Optics, Inc.October 6, 2023 | finance.yahoo.comCartica Acquisition Corp (CITE)September 20, 2023 | investing.comOmniLit Acquisition Corp. to Merge With Syntec OpticsMay 12, 2023 | marketwatch.comSyntec Optics, a Leading Optics and Photonics Company, to Publicly List on Nasdaq through Business Combination with OmniLit Acquisition Corp.May 12, 2023 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir Soon3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military SpendBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense3 Semiconductor Stocks Poised to Surge on AI SpendingBy Chris Markoch | June 25, 2025View 3 Semiconductor Stocks Poised to Surge on AI Spending3 AI Infrastructure Stocks With Strong Growth, Not HypeBy Chris Markoch | June 26, 2025View 3 AI Infrastructure Stocks With Strong Growth, Not HypeOLIT, DAIO, AXDX, and BNGO Company DescriptionsAccelerate Diagnostics NASDAQ:AXDXAccelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.Bionano Genomics NASDAQ:BNGO$3.45 +0.05 (+1.59%) As of 09:30 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.Data I/O NASDAQ:DAIO$3.24 +0.04 (+1.09%) As of 09:30 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Data I/O Corporation, together with its subsidiaries, engages in the design, manufacture, and sale of programming and security deployment systems and services for electronic device manufacturers in the United States, Europe, and internationally. Its programming system products are used to program integrated circuits (ICs) with the specific data for the ICs. The company offers PSV handlers off-line automated programming systems, such as PSV2800 automated programming system which focuses on high-volume manufacturing in a lower cost platform; PSV7000 automated programming system for security deployment upgrades; PSV5000 automated programming system that combines mid-range capacity and supports security deployment; and PSV3500 automated programming system which provides basic programming needs. It also provides SentriX security deployment system; and LumenX and non-automated FlashPAK III programming systems. In addition, the company offers hardware support, system installation and repair, and device programming services. It markets and sells its products to original equipment manufacturers in automotive and consumer electronics, internet of things, and industrial, as well as electronic manufacturing service contract manufacturers through direct sales, and indirect sales representatives and distributors. Data I/O Corporation was incorporated in 1969 and is headquartered in Redmond, Washington.OmniLit Acquisition NASDAQ:OLITOmniLit Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on transactions with companies and/or assets within the photonics or optics, and related sectors. The company was incorporated in 2021 and is based in Miami Beach, Florida. OmniLit Acquisition Corp. operates as a subsidiary of Omnilit Sponsor LLC. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/14 - 07/18 Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
